APA (7th ed.) Citation

F, Y., R, L., Z, F., Y, G., L, M., M, C., . . . K, H. (2026). Outcomes in patients with refractory/relapsed CNS lymphoma treated in complete remission: Autologous transplantation vs. CAR-T therapy. Cancer immunology, immunotherapy : CII, 75(4), . https://doi.org/10.1007/s00262-026-04334-x

Chicago Style (17th ed.) Citation

F, Yang, et al. "Outcomes in Patients with Refractory/relapsed CNS Lymphoma Treated in Complete Remission: Autologous Transplantation Vs. CAR-T Therapy." Cancer Immunology, Immunotherapy : CII 75, no. 4 (2026). https://doi.org/10.1007/s00262-026-04334-x.

MLA (9th ed.) Citation

F, Yang, et al. "Outcomes in Patients with Refractory/relapsed CNS Lymphoma Treated in Complete Remission: Autologous Transplantation Vs. CAR-T Therapy." Cancer Immunology, Immunotherapy : CII, vol. 75, no. 4, 2026, https://doi.org/10.1007/s00262-026-04334-x.